Hostname: page-component-cb9f654ff-nr592 Total loading time: 0 Render date: 2025-08-21T10:09:16.744Z Has data issue: false hasContentIssue false
  • English
  • Français

The Genetics of Obsessive-Compulsive Disorder: An Immunologic Perspective

Published online by Cambridge University Press:  07 November 2014

Mark Hyman Rapaport  and
Cathy G. McAllister
Get access Rights & Permissions [Opens in a new window]

Abstract

This article presents a rationale for the hypothesis that an autoimmune mechanism might be involved in the pathogenesis of some forms of obsessive-compulsive aborder (OCO). Existing clinical studies suggesting that some individuals with OCD may have an autoimmune-mediated disorder are briefly summarized. A case example where intravenous immunoglobulin G has been successfully used to treat an adult with OCD spectrum disorder is presented. Preclinical data demonstrating that fragments from the group Αβ hemolytic streptococcus cell wall M proteins can generate antibodies that bind to rat and human tissue are also presented.

Information

Type
Feature Articles
Information
CNS Spectrums , Volume 4 , Issue 6: Molecular Genetics: Part Two , June 1999 , pp. 71 - 77
Copyright
Copyright © Cambridge University Press 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

REFERENCES

1.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.Google Scholar
2.Holzer, JC, Goodman, WK, McDongle, CJ, et al.Obsessive-compulsive disorder with and without a chronic tic disorder: a comparison of symptoms in 70 patients. Br J Psychiatry. 1994;164:469–473.CrossRefGoogle ScholarPubMed
3.McDougle, CJ, Goodman, WK, Leckman, JF, et al.Haloperidol addition in fluvoxamine-refractory obsessive compulsive disorder: a double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry. 1994;51:302–308.CrossRefGoogle ScholarPubMed
4.Leckman, JF, Pauls, DL, Cohen, DJ. Tic disorders. In: Bloom, FE, Kupler, DJ, eds. Psychopharmacohgy: The Fourth Generatbn of Progress. New York, NY: Raven Press; 1995:1665–1674.Google Scholar
5.Swedo, SE, Leonard, HL, Schapira, MB, et al.Syndenham's chorea: physical and psychological symptoms of St. Vitus dance. Pediatrics. 1993;91:706–713.Google Scholar
6.Pauls, DL, Towbin, KE, Leckman, JF, et al.Gilles de la Tourette's syndrome and obsessive-compulsive disorder: evidence supporting a genetic relationship. Arch Gen Psychiatry. 1986;43:1180–1182.CrossRefGoogle ScholarPubMed
7.Swedo, SE, Leonard, HL, Kiesssling, LS. Speculations on antineuronal antibody-mediated neuropsychiatrie disorders of childhood. Pediatrics. 1994;93:323–326.CrossRefGoogle Scholar
8.Allen, AJ, Leonard, HL, Swedo, SE. Case study: a new infection-triggered autoimmune subtype of pediatric OCD and Tourette's syndrome. J Am Acad Child Adolesc Psychiatry. 1995;34:307–311.CrossRefGoogle ScholarPubMed
9.Swedo, SE. Sydenham's chorea: a model for childhood autoimmune neuropsychiatrie disorders. JAMA. 1994;2772:1788–1791.CrossRefGoogle Scholar
10.Husby, G, van de Rijn, I, Zabriskie, JB, et al.Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med. 1976;144:1094–1110.CrossRefGoogle ScholarPubMed
11.Wilcox, JA, Nasrallah, HA. Sydenham's chorea and psychosis. Neuropsychobiology. 1986;15:13–14.CrossRefGoogle ScholarPubMed
12.Grimshaw, L. Obsessional disorder and neurological illness. J Neurol Neurosurg Psychiatry. 1964;27:229–231.CrossRefGoogle ScholarPubMed
13.Freeman, JM, Aron, AM, Collard, JE, et al.The emotional correlates of Sydenham's chorea. Pediatrics. 1965;35:42–49.CrossRefGoogle ScholarPubMed
14.Swedo, SE, Rapoport, JL, Cheslow, DL, et al.High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am J Psychiatry. 1989;146:246–249.Google ScholarPubMed
15.Swedo, SE, Kilpatrick, K, Schapira, M, et al.Antineuronal antibodies in Sydenham's chorea and obsessive compulsive disorder. Pediatr Res. 1991;29:369a.Google Scholar
16.Beachey, EH, Seyer, JM, Dale, JB, et al.Type-specific protective immunity evoked by synthetic peptide of streptococcus pyogenes M protein. Macmillan Journals Ltd. 1981:13. Reprinted from Nature 1981;292:457–459.CrossRefGoogle Scholar
17.Edwin, H, Beachey, E, Jerome, M, et al.Repeating covalent structure and protective immunogenicity of native and synthetic polypeptide fragments of type 24 streptococcal M protein. Mapping of protective and nonprotective epitopes with monoclonal antibodies. J Biol Chemistry. 1983;258:13250–13257.Google Scholar
18.Dale, JB, Beachey, E. Multiple heart-cross-reactive epitopes of streptococcal M proteins. J Exp Med. 1985;161:113–122.CrossRefGoogle ScholarPubMed
19.Dale, JB, Beachey, EH. Sequence of myosin-crossreactive epitopes of streptococcal M protein. J Exp Med. 1986;164:1785–1790.CrossRefGoogle ScholarPubMed
20.Sargent, SJ, Beachey, EH, Corbett, CE, et al.Sequence of protective epitopes of streptococcal M proteins shared with cardiac sarcolemmal membranes. J Immunol. 1987;139:1285–1290.CrossRefGoogle ScholarPubMed
21.Kraus, W, Beachey, EH. Renal autoimmune epitope of group A streptococci specified by M protein tetrapeptide Ile-Arg-Leu-Arg. Proc Natl Acad Sci USA. 1988;85:4516–4520.CrossRefGoogle Scholar
22.Bronze, MS, Dale, JB. Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J Immunol. 1993;151:2820–2828.CrossRefGoogle ScholarPubMed
23.Regelmann, WE, Talbot, R, Cairns, L, et al.Distribution of cells bearing “rheumatic” antigens in peripheral blood of patients with rheumatic fever/rheumatic heart disease. J Rheumatol. 1989;16:931–935.Google ScholarPubMed
24.Gibofsky, A, Khanna, A, Suh, E, et al.The genetics of rheumatic fever: relationship to streptococcal infection and autoimmune disease. J Rheumatol. 1991;18(suppl 30):1–5.Google Scholar
25.Kiessling, LS, Marcotte, AC, Culpepper, L. Antineuronal antibodies in movement disorders. Pediatrics. 1993;92:39–43.CrossRefGoogle ScholarPubMed
26.Zabriskie, JB, Lavenchy, D, Williams, RC Jr, et al.Rheumatic fever-associated b cell alloantigens as identified by monoclonal antibodies. Arthritis Rheum. 1985;28:1047–1051.CrossRefGoogle ScholarPubMed
27.Kemeny, E, Husby, G, Williams, RC Jr, et al.Tissue distribution of antigen(s) defined by monoclonal antibody D8/17 reacting with b lymphocytes of patients with rheumatic heart disease. Clin Immunol Immunopathol. 1994;72:35–43.CrossRefGoogle ScholarPubMed
28.Khanna, AK, Buskirk, DR, Williams, RC Jr, et al.Presence of a non-HLA b cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest. 1989;83:1710–1716.CrossRefGoogle ScholarPubMed
29.Swedo, SE, Leonard, HL, Mittleman, BB, et al.Identification of children with pediatric autoimmune neuropsychiatrie disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry. 1997;154:110–112.Google Scholar
30.Murphy, TK, Goodman, WK, Fudge, MW, et al.B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome. Am J Psychiatry. 1997;154:402–407.Google ScholarPubMed
31.Hollander, E, DelGiudice-Asch, G, Simon, L, et al.B lymphocyte antigen D8/17 and repetitive behaviors in autism. Am J Psychiatry. 1999;156:317–320.CrossRefGoogle ScholarPubMed
32.Colony, HS, Malamud, N. Sydenham's chorea: a clinicopathologic study. Neurology. 1956;6:672–676.CrossRefGoogle ScholarPubMed
33.Ziegler, LH. The neuropathological findings in a case of acute Sydenham's chorea. J New Ment Dis. 1927;65:273–281.CrossRefGoogle Scholar
34.Goldman, S, Amron, D, Szliwowski, HB, et al.Reversible striatal hypermetabolism in a case of Sydenham's chorea. Mov Disord. 1993;8:355–358.CrossRefGoogle Scholar
35.Kienzle, GD, Berger, RK, Chun, RW, et al.Sydenham chorea: MR manifestations in two cases. AJNR. 1991;12:73–76.Google ScholarPubMed
36.Heye, N, Jergas, M, Hötzinger, H, et al.Sydenham chorea: clinical, EEG, MRI and SPECT findings in the early stage of the disease. J Neurol. 1993;240:121–123.CrossRefGoogle ScholarPubMed
37.Singer, HS, Reiss, AL, Brown, JE, et al.Volumetrie MRI changes in basal ganglia of children with Tourette syndrome. Neurobgy. 1993;43:950–956.Google Scholar
38.Peterson, MD, Riddle, MA, Cohen, DJ, et al.Reduced basal ganglia volumes in Tourette syndrome using three-dimensional reconstruction techniques from magnetic resonance images. Neurobgy. 1993;43:941–949.Google ScholarPubMed
39.Kiessling, LS, Marcotte, AC, Culpepper, L. Antineuronal antibodies: tics and obsessive-compulsive symptoms. DEBP. 1994;15(6):421–425.Google ScholarPubMed
40.Swedo, SE, Leonard, HL, Garvey, M, et al.Pediatric autoimmune neuropsychiatrie disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155:264–271.CrossRefGoogle Scholar
41.Swedo, SE, Leonard, HL, Kiessling, LS. Commentaries: speculations on antineuronal antibody-mediated neuropsychiatrie disorders of childhood. Pediatrics. 1994;93:323–326.CrossRefGoogle Scholar